Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Surgery;

Glaucoma in Conjunction with Cataract and Stand Alone Glaucoma.

By Target;

Trabecular Meshwork, Suprachoroidal Space, and Others.

By Product;

MIGS Stents, MIGS Shunts, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn393639173 Published Date: May, 2024 Updated Date: June, 2024

Introduction

Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market (USD Million), 2020 - 2030

In the year 2023, the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market was valued at USD 516.92 million. The size of this market is expected to increase to USD 2,457.97 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 25.0%.

The Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market caters to the increasing demand for advanced treatment options in the field of ophthalmology. Glaucoma, a leading cause of irreversible blindness worldwide, necessitates effective interventions to manage intraocular pressure (IOP) and preserve vision. MIGS devices represent a revolutionary approach, offering minimally invasive procedures that aim to alleviate glaucoma symptoms while minimizing patient discomfort and recovery time.

The market is witnessing significant growth driven by several factors. Firstly, the rising prevalence of glaucoma globally, particularly among aging populations, underscores the urgent need for innovative treatment modalities. MIGS devices, characterized by their safety, efficacy, and rapid patient recovery, are increasingly preferred over traditional surgical techniques due to their ability to provide sustained IOP reduction with fewer complications.

Technological advancements in MIGS devices have enhanced their performance and expanded their applicability in diverse patient populations. Manufacturers are continually innovating to develop next-generation MIGS devices with improved precision, customization, and compatibility, thereby broadening the scope of treatment options available to ophthalmologists and patients.

The growing adoption of MIGS procedures by eye care professionals reflects a paradigm shift towards less invasive surgical approaches in glaucoma management. As healthcare systems worldwide prioritize value-based care and patient-centric outcomes, MIGS devices offer a compelling solution by combining therapeutic efficacy with enhanced safety profiles and improved quality of life for glaucoma patients.

The market remains poised for substantial expansion, driven by ongoing technological innovations, increasing awareness of glaucoma management, and growing patient demand for minimally invasive treatment options. As manufacturers continue to invest in research and development and collaborate with healthcare stakeholders to address market challenges, the outlook for MIGS devices appears promising, with the potential to revolutionize glaucoma care and improve visual outcomes for patients worldwide.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Surgery
    2. Market Snapshot, By Target
    3. Market Snapshot, By Product
    4. Market Snapshot, By Region
  4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising glaucoma prevalence
        2. Demand surge for minimally invasive surgeries
        3. Aging population's susceptibility
        4. Increased glaucoma awareness
      2. Restraints
        1. Surgeon training scarcity
        2. Regulatory hurdles for device approval
        3. Efficacy and safety concerns
        4. Traditional treatment reluctance
      3. Opportunities
        1. Integrated treatment protocols
        2. Value-based care adoption
        3. Patient education initiatives
        4. Post-market surveillance enhancement
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery, 2020 - 2030 (USD Million)
      1. Glaucoma in Conjunction with Cataract
      2. Stand Alone Glaucoma
    2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Target, 2020 - 2030 (USD Million)
      1. Trabecular Meshwork
      2. Suprachoroidal Space
      3. Others
    3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product, 2020 - 2030 (USD Million)
      1. MIGS Stents
      2. MIGS Shunts
      3. Others
    4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Alcon, Inc.
      2. Glaukos Corporation.
      3. Johnson & Johnson Vision
      4. AbbVie Inc. (Allergan Plc.)
      5. Corza Ophthalmology
      6. Carl Zeiss Meditec AG
      7. Katalyst Surgical
      8. Lumenis Ltd
      9. Ziemer Ophthalmic Systems AG
      10. Iridex Corporation
  7. Analyst Views
  8. Future Outlook of the Market